Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpoint.
Hanke CW, Narins RS, Brandt F, Cohen JL, Donofrio LM, Downie J, Heinz M, Harrington L, McDaniel DH, Nestor M, Schlessinger J, Schlöbe A, Taub A, Weiss RA. Hanke CW, et al. Among authors: brandt f. Dermatol Surg. 2013 Jun;39(6):891-9. doi: 10.1111/dsu.12160. Epub 2013 Mar 18. Dermatol Surg. 2013. PMID: 23506308 Clinical Trial.
Evaluation of variable-dose treatment with a new U.S. Botulinum Toxin Type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study.
Kane MAC, Brandt F, Rohrich RJ, Narins RS, Monheit GD, Huber MB; Reloxin Investigational Group. Kane MAC, et al. Among authors: brandt f. Plast Reconstr Surg. 2009 Nov;124(5):1619-1629. doi: 10.1097/PRS.0b013e3181b5641b. Plast Reconstr Surg. 2009. PMID: 19584772 Clinical Trial.
12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel soft-tissue filler.
Narins RS, Coleman WP 3rd, Rohrich R, Monheit G, Glogau R, Brandt F, Bruce S, Colen L, Dayan S, Jackson I, Maas C, Rivkin A, Sclafani A, Spivak JC. Narins RS, et al. Among authors: brandt f. Dermatol Surg. 2010 Nov;36 Suppl 3:1819-29. doi: 10.1111/j.1524-4725.2010.01736.x. Dermatol Surg. 2010. PMID: 20969659 Clinical Trial.
265 results